Publication:
The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders.

cris.virtual.author-orcid0000-0003-4179-8891
cris.virtualsource.author-orcid3bee1d6a-134c-4ed9-a1b8-a49005692c8e
cris.virtualsource.author-orcid6eb58dfd-9fde-4638-ad45-a6946d31d2e0
cris.virtualsource.author-orcid8b8f5685-4c23-448f-9bd6-f5fb35ff7670
datacite.rightsopen.access
dc.contributor.authorMilusev, Anastasia
dc.contributor.authorRieben, Robert
dc.contributor.authorSorvillo, Nicoletta
dc.date.accessioned2024-10-11T16:37:09Z
dc.date.available2024-10-11T16:37:09Z
dc.date.issued2022-05
dc.description.abstractThe physiological, anti-inflammatory, and anti-coagulant properties of endothelial cells (ECs) rely on a complex carbohydrate-rich layer covering the luminal surface of ECs, called the glycocalyx. In a range of cardiovascular disorders, glycocalyx shedding causes endothelial dysfunction and inflammation, underscoring the importance of glycocalyx preservation to avoid disease initiation and progression. In this review we discuss the physiological functions of the glycocalyx with particular focus on how loss of endothelial glycocalyx integrity is linked to cardiovascular risk factors, like hypertension, aging, diabetes and obesity, and contributes to the development of thrombo-inflammatory conditions. Finally, we consider the role of glycocalyx components in regulating inflammatory responses and discuss possible therapeutic interventions aiming at preserving or restoring the endothelial glycocalyx and therefore protecting against cardiovascular disease.
dc.description.sponsorshipDepartment for BioMedical Research, Forschungsbereich Murtenstrasse 50
dc.description.sponsorshipDepartment for BioMedical Research, Forschungsgruppe Handchirurgie
dc.description.sponsorshipDepartment for BioMedical Research (DBMR)
dc.identifier.doi10.48350/170402
dc.identifier.pmid35647072
dc.identifier.publisherDOI10.3389/fcvm.2022.897087
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/85389
dc.language.isoen
dc.publisherFrontiers
dc.relation.ispartofFrontiers in cardiovascular medicine
dc.relation.issn2297-055X
dc.relation.organizationDCD5A442C5F4E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BD18E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C26FE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C39CE17DE0405C82790C4DE2
dc.relation.schoolDCD5A442C27BE17DE0405C82790C4DE2
dc.subjectatherosclerosis cardiovascular risk factor endothelial cell (EC) glycocalyx heparan sulfate (HS) inflammation ischemia/reperfusion injury therapeutic target
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleThe Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.startPage897087
oaire.citation.volume9
oairecerif.author.affiliationDepartment for BioMedical Research, Forschungsbereich Murtenstrasse 50
oairecerif.author.affiliationDepartment for BioMedical Research, Forschungsgruppe Handchirurgie
oairecerif.author.affiliationDepartment for BioMedical Research (DBMR)
oairecerif.author.affiliation2Department for BioMedical Research, Forschungsgruppe Herz und Gefässe
oairecerif.author.affiliation3Department for BioMedical Research, Forschungsbereich Murtenstrasse 50
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2022-06-02 07:52:42
unibe.description.ispublishedpub
unibe.eprints.legacyId170402
unibe.refereedtrue
unibe.subtype.articlereview

Files

Original bundle
Now showing 1 - 1 of 1
Name:
fcvm-09-897087.pdf
Size:
2.23 MB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by/4.0
Content:
published

Collections